Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential
Annals of the New York Academy of Sciences · 2024
DOI: 10.1111/nyas.15220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of the New York Academy of Sciences, 2024. Verfasst von Aaran H Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Kisspeptins, Amenorrhea, Gonadotropin-Releasing Hormone, Hypothalamus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 264 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
Functional hypothalamic amenorrhea (FHA) is one of the most common causes of secondary amenorrhea, resulting in anovulation and infertility, and is a low estrogen state that increases the risk of cardiovascular disease and impairs bone health. FHA is characterized by acquired suppression of physiological pulsatile gonadotropin‐releasing hormone (GnRH) release by the hypothalamus in the absence of an identifiable structural cause, resulting in a functional hypogonadotropic hypogonadism. FHA results from either decreased energy intake and/or excessive exercise, leading to low energy availability and weight loss—often in combination with psychological stress on top of a background of genetic susceptibility. The hypothalamic neuropeptide kisspeptin is a key component of the GnRH pulse generator, tightly regulating pulsatile GnRH secretion and the downstream reproductive axis. Here, we review the physiological regulation of pulsatile GnRH secretion by hypothalamic kisspeptin neurons and how their activity is modulated by signals of energy status to affect reproductive function. We explore endocrine factors contributing to the suppression of GnRH pulsatility in the pathophysiology of FHA and how hypothalamic kisspeptin neurons likely represent a final common pathway through which these factors affect GnRH pulse generation. Finally, we discuss the therapeutic potential of kisspeptin as a novel treatment for women with FHA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology and Investigative Medicine, Imperial College London, London, UK.
- Department of Endocrinology, Chelsea and Westminster Hospital, London, UK.
- Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
ORCID-Profile: Aaran H Patel
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Patel, A. H., Koysombat, K., Pierret, A., Young, M., Comninos, A. N., Dhillo, W. S., & Abbara, A. (2024). Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential. Annals of the New York Academy of Sciences. https://doi.org/10.1111/nyas.15220
Vancouver
Patel AH, Koysombat K, Pierret A, Young M, Comninos AN, Dhillo WS, et al. Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential. Annals of the New York Academy of Sciences. 2024. doi:10.1111/nyas.15220
BibTeX
@article{Patel2024,
author = {Patel, Aaran H and Koysombat, Kanyada and Pierret, Aureliane and Young, Megan and Comninos, Alexander N and Dhillo, Waljit S and Abbara, Ali},
title = {Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential},
journal = {Annals of the New York Academy of Sciences},
year = {2024},
doi = {10.1111/nyas.15220}
}
EUVIMED